The effect of smoking on the duration of life with and without disability, Belgium 1997–2011

BMC Public Health

Stefaan Demarest⁴  Jean-Marie Robine²  Emmanuelle Cambois⁵  Carol Jagger¹  Rana Charafeddine⁴  Wilma Nusselder³  Nicolas Berger⁴  Herman Van Oyen⁴ 

[1]Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, United Kingdom

[2]French Institute of Health and Medical Research, INSERM, Paris and Montpellier, France

[3]Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, the Netherlands

[4]Unit of Survey, Life Styles and Chronic Diseases, Directorate Public Health and Surveillance, Scientific Institute of Public Health, Brussels, Belgium

[5]French Institute for Demographic Studies, INED, Paris, France

关键词: Belgium;    Decomposition;    Smoking;    Mortality;    Disability;    Health expectancy;    Life expectancy;    Disability life expectancy;    Disability free life expectancy;   

Others  :  1129000
DOI  :  10.1186/1471-2458-14-723

 received in 2013-12-08, accepted in 2014-07-01,  发布年份 2014

【 摘 要 】

Background

Smoking is the single most important health threat yet there is no consistency as to whether non-smokers experience a compression of years lived with disability compared to (ex-)smokers. The objectives of the manuscript are (1) to assess the effect of smoking on the average years lived without disability (Disability Free Life Expectancy (DFLE)) and with disability (Disability Life Expectancy (DLE)) and (2) to estimate the extent to which these effects are due to better survival or reduced disability in never smokers.

Methods

Data on disability and mortality were provided by the Belgian Health Interview Survey 1997 and 2001 and a 10 years mortality follow-up of the survey participants. Disability was defined as difficulties in activities of daily living (ADL), in mobility, in continence or in sensory (vision, hearing) functions. Poisson and multinomial logistic regression models were fitted to estimate the probabilities of death and the prevalence of disability by age, gender and smoking status adjusted for socioeconomic position. The Sullivan method was used to estimate DFLE and DLE at age 30. The contribution of mortality and of disability to smoking related differences in DFLE and DLE was assessed using decomposition methods.

Results

Compared to never smokers, ex-smokers have a shorter life expectancy (LE) and DFLE but the number of years lived with disability is somewhat larger. For both sexes, the higher disability prevalence is the main contributing factor to the difference in DFLE and DLE. Smokers have a shorter LE, DFLE and DLE compared to never smokers. Both higher mortality and higher disability prevalence contribute to the difference in DFLE, but mortality is more important among males. Although both male and female smokers experience higher disability prevalence, their higher mortality outweighs their disability disadvantage resulting in a shorter DLE.

Conclusion

Smoking kills and shortens both life without and life with disability. Smoking related disability can however not be ignored, given its contribution to the excess years with disability especially in younger age groups.

【 授权许可】

   
2014 Van Oyen et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]World Health Organisation: WHO Global Report: Mortality Attributable To Tobacco. Geneva: WHO; 2012:1-396.
• [2]Mathers CD, Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3:e442.
• [3]Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, McAfee T, Peto R: 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013, 368:341-350.
• [4]Sakata R, McGale P, Grant EJ, Ozasa K, Peto R, Darby SC: Impact of smoking on mortality and life expectancy in Japanese smokers: a prospective cohort study. BMJ 2012, 345:e7093.
• [5]Pirie K, Peto R, REEVES GK, Green J, Beral V: The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet 2013, 381:133-141.
• [6]Frosch ZAK, Dierker LC, Rose JS, Waldinger RJ: Smoking trajectories, health, and mortality across the adult lifespan. Addict Behav 2009, 34:701-704.
• [7]Levy DT, Ellis JA, Mays D, Huang AT: Smoking-related deaths averted due to three years of policy progress. Bull World Health Organ 2013, 91:509-518.
• [8]Al Mamun A, Peeters A, Barendregt J, Willekens F, Nusselder W, Bonneux L: Smoking decreases the duration of life lived with and without cardiovascular disease: a life course analysis of the Framingham Heart Study. Eur Heart J 2004, 25:409-415.
• [9]Devereux G: ABC of chronic obstructive pulmonary disease. Definition, epidemiology, and risk factors. BMJ 2006, 332:1142-1144.
• [10]Lee PN, Forey BA, Coombs KJ: Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer. BMC Cancer 2012, 12:385.
• [11]Artaud F, Dugravot A, Sabia S, Singh-Manoux A, Tzourio C, Elbaz A: Unhealthy behaviours and disability in older adults: Three-City Dijon cohort study. BMJ 2013, 347:f4240.
• [12]Strandberg AY, Strandberg TE, Pitkälä K, Salomaa VV, Tilvis RS, Miettinen TA: The effect of smoking in midlife on health-related quality of life in old age: a 26-year prospective study. Arch Intern Med 2008, 168:1968-1974.
• [13]Belanger A, Martel L, Berthelot JM, Wilkins R: Gender differences in disability-free life expectancy for selected risk factors and chronic conditions in Canada. J Women Aging 2002, 14:61-83.
• [14]Ferrucci L, Izmirlian G, LEVEILLE S, Phillips CL, Corti MC, Brock DB, Guralnik JM: Smoking, physical activity, and active life expectancy. Am J Epidemiol 1999, 149:645-653.
• [15]Klijs B, Mackenbach JP, Kunst AE: Obesity, smoking, alcohol consumption and years lived with disability: a Sullivan life table approach. BMC Public Health 2011, 11:378.
• [16]Majer IM, Nusselder WJ, Mackenbach JP, Kunst AE: Life expectancy and life expectancy with disability of normal weight, overweight, and obese smokers and nonsmokers in Europe. Obes 2011, 19:1451-1459.
• [17]Reuser M, Bonneux L, Willekens F: Smoking kills, obesity disables: a multistate approach of the U.S. Health and Retirement Survey. Obesity 2009, 17:783-789.
• [18]Bronnum-Hansen H, Juel K: Abstention from smoking extends life and compresses morbidity: a population based study of health expectancy among smokers and never smokers in Denmark. Tob Control 2001, 10:273-278.
• [19]Bronnum-Hansen H, Juel K, Davidsen M, Sorensen J: Impact of selected risk factors on expected lifetime without long-standing, limiting illness in Denmark. Prev Med 2007, 45:49-53.
• [20]Nusselder WJ, Looman CWN, Marang-van de Mheen PJ, van de Mheen H, Mackenbach JP: Smoking and the compression of morbidity. J Epidemiol Community Health 2000, 54:566-574.
• [21]Gruenberg E: The failure of success. The Milbank Memorial Fund Quarterly/Health Soc 1977, 55:3-24.
• [22]Fries JF, Bruce B, Chakravarty E: Compression of morbidity 1980–2011: a focused review of paradigms and progress. J Aging Res 2011, 2011:261702.
• [23]Demarest S, Van der Heyden J, Charafeddine R, Drieskens S, Gisle L, Tafforeau J: Methodological basics and evolution of the Belgian Health Interview Survey 1997–2008. Arch Public Health 2013, 71:24.
• [24]de Bruin A, Picavet HS, Nossikov A: Health Interview Surveys: Towards International Harmonization of Methods and Instruments. World Health Organisation: Copenhagen; 1996.
• [25]Ware JE, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-483.
• [26]Unesco Institute for Statistics: International Standard Classification of Education, ISCED 2011. Montreal: UNESCO; 2012:1-88.
• [27]Kirkwood B, Sterne J: Poisson Regression. In Essential Medical Statistics. second edition. Edited by Kirkwood B, Sterne J. Malden, MA: Blackwell Science; 2003:249-262.
• [28]Charafeddine R, Van Oyen H, Demarest S: Does the association between smoking and mortality differ by socioeconomic status? Soc Sci Med 2012, 74:1402-1406.
• [29]Charafeddine R, Demarest S, Van der Heyden J, Tafforeau J, Van Oyen H: Using multiple measures of social inequalities to study time trends in smoking inequalities. Eur J Publ Health 2012, 23:546-551.
• [30]Jagger C, Cox B, Le Roy S, Clavel A, Robine JM, Romieu I, Van Oyen H: Health Expectancy Calculation by the Sullivan Method: A Practical Guide. Third edition. 2007. (http://www.eurohex.eu/pdf/Sullivan_guide_final_jun2007.pdf webcite). EHEMU Technical report 2006_3, 1-44. 2007. Montpellier, France
• [31]Sullivan DF: A single index of mortality and morbidity. HSMHA Health Rep 1971, 86:347-354.
• [32]Nusselder W, Jagger C, Cox B, Cambois E, Van Oyen H, Robine JM, Doblhammer G, Rychtarikova J, Gillies C, Weston C, Kruse A, Beluche I, Counienc R, Hassen-Khodja C, Romieu I, Perrier C: WP7: Decomposition Tools. Technical Report on Decomposition. (http://www.eurohex.eu/pdf/Reports_2010/2010TR7.1_Decomposition%20tools.pdf webcite). EHEMU Technical report 2010_7.1, 1–49. 2010. Montpellier, France
• [33]Nusselder WJ, Looman CW: Decomposition of differences in health expectancy by cause. Demography 2004, 41:315-334.
• [34]Robine JM, Cambois E, Nusselder W, Jeune B, Van Oyen H, Jagger C: The joint action on healthy life years (JA: EHLEIS). Arch Public Health 2013, 71:2.
• [35]Van Oyen H, Nusselder W, Jagger C, Kolip P, Cambois E, Robine JM: Gender differences in healthy life years within the EU: an exploration of the “health-survival” paradox. Int J Public Health 2013, 58:143-155.
• [36]Azagba S, Sharaf MF, Xiao LC: Disparities in health care utilization by smoking status in Canada. Int J Public Health 2013, 58:913-925.
• [37]Holahan CK, Holahan CJ, North RJ, Hayes RB, Powers DA, Ockene JK: Smoking status, physical health-related quality of life, and mortality in middle-aged and older women. Nicotine Tob Res 2013, 15:662-669.
• [38]Laaksonen M, Rahkonen O, Martikainen P, Karvonen S, Lahelma E: Smoking and SF-36 health functioning. Prev Med 2006, 42:206-209.
• [39]Nolte E, Mckee M: Variations in amenable mortality–trends in 16 high-income nations. Health Policy 2011, 103:47-52.
• [40]Mathers CD, Robine JM: How good is Sullivan’s method for monitoring changes in population health expectancies. J Epidemiol Community Health 1997, 51:80-86.
• [41]Galea S, Tracy M: Participation rates in epidemiologic studies. Ann Epidemiol 2007, 17:643-653.
• [42]Demarest S, Van der Heyden J, Charafeddine R, Tafforeau J, Van Oyen H, Van Hal G: Socio-economic differences in participation of households in a Belgian national health survey. Eur J Publ Health 2012, 23:981-985.
• [43]Lorant V, Demarest S, Miermans PJ, Van Oyen H: Survey error in measuring socio-economic risk factors of health status: a comparison of a survey and a census. Int J Epidemiol 2007, 36:1292-1299.
• [44]Charafeddine R, Berger N, Demarest S, Van Oyen H: Using mortality follow-up of surveys to estimate social inequalities in healthy life years. Popul Health Metrics 2014, 12:13.
• [45]Vartiainen E, Seppala T, Lillsunde P, Puska P: Validation of self reported smoking by serum cotinine measurement in a community-based study. J Epidemiol Community Health 2002, 56:167-170.
• [46]Lagiewka K: European innovation partnership on active and healthy ageing: what have been the policy drivers and determinants to set a headline target of 2 additional Healthy Life Years at birth at EU average by 2020? Arch Public Health 2012, 70:23.